RxDoctor Payments Data

Brett Duplantis

Physician Assistant · Cut Off, LANPI 1073660676

Payments from drug & device makers

$3,360in general payments, 2019–2025

Across 171 payments — averaging $19.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$616
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$569
  • Novo Nordisk$459
  • AstraZeneca$222
  • GSK$212
  • Lilly USA, LLC$167
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$3,360100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,360 in reported general payments places this provider in the 85th percentile of 1,246 physician assistant providers in Louisiana.

See all physician assistant providers in Louisiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide27$27,590
OzempicSemaglutide15$16,904
Orphenadrine-Aspirin-CaffeineOrphenadrine/Aspirin/Caffeine14$10,061
Albuterol Sulfate HfaAlbuterol Sulfate47$1,355
Fluticasone Propionate108$1,315
Quetiapine Fumarate29$465
Omeprazole31$429
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav29$333
Pregabalin22$294
Mupirocin35$276
Amitriptyline Hcl17$253
Bisoprolol Fumarate12$245
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine11$238
Levothyroxine Sodium27$233
Baclofen34$221

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$167$27,59027 claims
Novo NordiskOzempic$459$16,90415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,246 physician assistant providers in Louisiana.

Other physician assistant in Cut Off

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →